Historical and current end-of-day data provided by FACTSET. All quotes are in local exchange time. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed at least 15 minutes or per exchange requirements. Close Trending Tickers bar ...
MESO Mesoblast Limited Stock Price & Overview Analyze With AIFollow6.76K followers $16.87-0.36 (-2.09%)11:03 AM 02/21/25 NASDAQ | $USD | Delayed SummaryRatingsFinancialsEarningsDividendsValuationGrowthProfitabilityMomentumPeersOptionsChartingAll
Historical and current end-of-day data provided by FACTSET. All quotes are in local exchange time. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed at least 15 minutes or per exchange requirements. ...
USDNasdaq Global SelectDelayed PriceMarket Closed Earnings High Target Price 30.00 Mean Target Price 27.00 Low Target Price 24.00 Standard Deviation: 4.24 Number of Estimates 2 Date of Most Recent Estimate 02/07/25 # Estimates: 2232425262728293031 Mean27.00 High30.00 Low24.00 Price Estimate# Estimates...
Biotechnology Pharmaceuticals, Biotechnology & Life Sciences Health Care NASDAQ Biotechnology NASDAQ Composite NASDAQ Health Care Pharmaceutical Products Cancer Fighters To learn how to invest in Mesoblast Stock, please use our How to Invest in Mesoblast guide. You can also try the USA ETFs module ...
Revenue Per Share 0.06 Quarterly Revenue Growth (0.41) Return On Assets (0.05) Return On Equity (0.18) The market value of Mesoblast is measured differently than its book value, which is the value of Mesoblast that is recorded on the company's balance sheet. Investors also form their ...
1.14B Stock Price 17.15 Revenue $0000 About Mesoblast Mesoblast specializes in the development and commercialization of innovative allogeneic cellular medicines for the treatment of serious and life-threatening inflammatory diseases within the biotechnology sector. The company's main offerings include a sui...
Market Cap $1B Current Price $11.65 NASDAQ: CRSP CRISPR Therapeutics Market Cap $4B Current Price $44.40 NASDAQ: GRAL Grail Market Cap $1B Current Price $43.87 NASDAQ: KNSA Kiniksa Pharmaceuticals International, Plc Market Cap $1B Current Price $19.69 Premium...